British multinational AI biotech company from London (DeepMind spin-off, Alphabet Inc. subsidiary). Founded 2021 by Sir Demis Hassabis (2024 Nobel laureate for AlphaFold). Builds a Drug Design Engine on AlphaFold 3 foundations. Series A $600M @ Thrive Capital, partnerships: Novartis, Eli Lilly, Johnson & Johnson.
Founder & CEO. Concurrent CEO of DeepMind (parent spin-off origin). 2024 Nobel Prize in Chemistry laureate for AlphaFold (jointly with John Jumper and David Baker). Knight of the United Kingdom (2024).
